YONGAN PHARMACEUTICAL issued a notice of unusual movement, stating that the company's recent operating conditions are normal and there have been no significant changes in the internal and external operating environment; the company, its controlling shareholders, and actual controllers do not have any significant matters related to the company that should be disclosed but have not been disclosed, nor are there any significant matters in the planning stage